Optimal Therapy for Helicobacter Pylori Infection ConferenceWe have the pleasure to invite you to attend the 1st Conference on Optimal Therapy for Helicobacter Infection, scheduled to be held at Intercontinental Hotel, Abu Dhabi on October 5, 2012.
Helicobacter pylori (H. pylori) infection is both the most common chronic human and a serious bacterial infections and the major risk factor for peptic ulcer disease and gastric cancer. (80% in developing countries, 10-50% in the US) HP is a WHO class I (definite) carcinogen, HP infected patients suffer major morbidities (10-15% peptic ulcer, 1-2% gastric adenocarcinoma and 0.1% MALTOMA)
The conference aims to review in depth various issues involving H. pylori infection from various perspectives. A wide array of topics of interests will be addressed by renowned faculty of speakers and leading experts in this field.
The conference will provide practicing physicians with a unique opportunity to network with their peers and keep abreast of the latest updates in H Pylori.
We look forward to your participation and hope to see you on October 5, 2012 to make the conference a success.
Please do not miss this outstanding opportunity!
Dr. Makki Fayadh